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The serotonin1A (5-HT1A) receptor is an important member of the superfamily of seven transmembrane domain G-protein cou-
pled receptors (GPCRs). We report here that guanine nucleotide sensitivity of agonist binding to hippocampal 5-HT1A receptors is
dependent on the concentration of Mg2+. Our results show that agonist binding to 5-HT1A receptors is relatively insensitive to guan-
ine nucleotides in the absence of Mg2+. In contrast to this, the specific antagonist binding is insensitive to guanine nucleotides, even
in the presence of Mg2+. These results point out the requirement of an optimal concentration of Mg2+ which could be used in assays
toward determining guanine nucleotide sensitivity of ligand binding to GPCRs such as the 5-HT1A receptor. Our results provide
novel insight into the requirement and concentration dependence of Mg2+ in relation to guanine nucleotide sensitivity for the
5-HT1A receptor in particular, and GPCRs in general.
 2004 Elsevier Inc. All rights reserved.
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2+; 8-OH-DPAT; p-MPPF; Bovine hippocampusSerotonin (5-hydroxytryptamine or 5-HT) is an
intrinsically fluorescent [1], biogenic amine which acts
as a neurotransmitter and is found in a wide variety of
sites in the central and peripheral nervous systems [2].
Serotonergic signaling appears to play a key role in
the generation and modulation of various cognitive
and behavioral functions including sleep, mood, pain,
addiction, locomotion, sexual activity, depression, anxi-
ety, alcohol abuse, aggression, and learning [3,4]. Dis-
ruptions in serotonergic systems have been implicated0006-291X/$ - see front matter  2004 Elsevier Inc. All rights reserved.
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E-mail address: amit@ccmb.res.in (A. Chattopadhyay).in the etiology of mental disorders such as schizophre-
nia, migraine, depression, suicidal behavior, infantile
autism, eating disorders, and obsessive compulsive dis-
order [3,5].
Serotonin exerts its diverse actions by binding to dis-
tinct cell surface receptors which have been classified
into many groups [6]. Serotonin receptors are members
of a superfamily of seven transmembrane domain G-
protein coupled receptors [7] that couple to and trans-
duce signals via guanine nucleotide binding regulatory
proteins (G-proteins) [8]. Among the 14 subtypes of
serotonin receptors, the G-protein coupled 5-HT1A
receptor is the best characterized for a number of rea-
sons [9,10]. We have earlier partially purified and solubi-
lized the 5-HT1A receptor from bovine hippocampus in
a functionally active form [11,12]. We have also reported
the solubilization of 5-HT1A receptors stably expressed
in Chinese hamster ovary (CHO) cells [13]. In addition,
we have shown modulation of ligand binding to 5-HT1A
receptors by metal ions [9,14], agents that perturb
Table 1
Extent of inhibition in specific [3H]8-OH-DPAT binding in the
presence of GTP-c-S and IC50 values of GTP-c-S at different
concentrations of MgCl2
a
Concentration of
MgCl2 (mM)
Extent of inhibition
in agonist binding (%)
IC50 of
GTP-c-S (nM)
0 26.6 —
0.5 35.2 620
2 87.8 93
10 91.3 92
a The values reported are obtained from Fig. 2. See Materials and
methods for other details.
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ifications of the disulfide and sulfhydryl groups [10], and
membrane cholesterol [18,19].
The hippocampal 5-HT1A receptor is negatively cou-
pled to adenylate cyclase through Gi-proteins [20]. Ago-
nist binding of the 5-HT1A receptor has previously been
shown to be modulated by guanine nucleotides [15,21].
Activation of a G-protein coupled receptor upon bind-
ing to its ligand sets the stage for a series of events in
the G-protein cycle [22] and Mg2+ is known to be one
of the crucial components at various steps of this cycle
[23,24]. In this report, we show that guanine nucleotide
sensitivity of agonist binding to hippocampal 5-HT1A
receptors is dependent on the concentration of Mg2+.
Our results show that agonist binding is relatively insen-
sitive to guanine nucleotides in the absence of Mg2+.
However, the antagonist binding is insensitive to guan-
ine nucleotides, even in the presence of Mg2+.Materials and methods
Materials. EDTA, EGTA, iodoacetamide, MgCl2, p-MPPI, PMSF,
polyethylenimine, Tris, serotonin, sodium azide, and sucrose were
obtained from Sigma Chemical (St. Louis, MO, USA). GTP-c-S was
purchased from Roche Applied Science (Mannheim, Germany). [3H]8-
OH-DPAT (sp. activity 135.0 Ci/mmol) and [3H]p-MPPF (sp. activity
70.5 Ci/mmol) were purchased from DuPont New England Nuclear
(Boston, MA, USA). BCA reagent kit for protein estimation was ob-
tained from Pierce (Rockford, IL, USA). All other chemicals used were
of the highest purity available. GF/B glass microfiber filters were from
Whatman International (Kent, UK). Fresh bovine brains were ob-
tained from a local slaughterhouse within 10 min of death and the
hippocampal region was carefully dissected out. The hippocampi were
immediately flash-frozen in liquid nitrogen and stored at 70 C until
further use.
Preparation of native hippocampal membranes. Native hippocampal
membranes were prepared as described earlier [9]. Bovine hippocampal
tissue (100 g) was homogenized as 10% (w/v) with a polytron
homogenizer in buffer A (2.5 mM Tris, 0.32 M sucrose, 5 mM EDTA,
5 mM EGTA, 0.02% sodium azide, 0.24 mM PMSF, and 10 mM
iodoacetamide, pH 7.4). The homogenate was centrifuged at 900g for
10 min at 4 C. The supernatant was filtered through four layers of
cheesecloth and the pellet was discarded. The supernatant was further
centrifuged at 50,000g for 20 min at 4 C. The resulting pellet was
suspended in 10 vol buffer B (50 mM Tris, 1 mM EDTA, 0.24 mM
PMSF, and 10 mM iodoacetamide, pH 7.4) using a hand-held Dounce
homogenizer and centrifuged at 50,000g for 20 min at 4 C. This
procedure was repeated until the supernatant was clear. The final pellet
(native membrane) was resuspended in a minimum volume of buffer C
(50 mM Tris, pH 7.4), homogenized using a hand-held Dounce
homogenizer, flash-frozen in liquid nitrogen, and stored at 70 C
until further use. Protein concentration was determined using the BCA
reagent with bovine serum albumin as standard [25].
Radioligand binding assays. Receptor binding assays for agonist
and antagonist were carried out as described earlier [15] with a few
modifications in the presence of increasing concentrations of Mg2+.
Briefly, tubes in duplicate containing 1 mg total protein in a total
volume of 1 ml buffer D (50 mM Tris, 1 mM EDTA, pH 7.4) were used
with increasing concentrations of MgCl2. Tubes were incubated with
the radiolabeled agonist [3H]8-OH-DPAT (final concentration in the
assay tube being 0.29 nM) or antagonist [3H]p-MPPF (final concen-tration in the assay tube being 0.5 nM) for 1 h at room temperature.
Non-specific binding was determined by performing the assay in the
presence of 10 lM unlabeled 5-HT in case of agonist binding or 10 lM
unlabeled p-MPPI in case of antagonist binding. The incubation was
terminated by rapid filtration under vacuum in a Millipore multiport
filtration apparatus through Whatman GF/B 2.5 cm diameter (1.0 lm
pore size) glass microfiber filters which were presoaked in 0.15% (w/v)
polyethylenimine for 3 h [26]. The filters were then washed three times
with 3 ml ice-cold water, dried, and the retained radioactivity was
measured in a Packard Tri-Carb 1500 scintillation counter using 5 ml
scintillation fluid.
Sensitivity to GTP-c-S. Ligand binding assays at a specified con-
centration of MgCl2 were performed in the presence of varying con-
centrations of GTP-c-S as described earlier [17] with a few
modifications. The concentrations of GTP-c-S leading to 50% inhibi-
tion of specific agonist binding (IC50) were calculated by non-linear
regression fitting of the data to a four parameter logistic function [27]:
B ¼ a
1þ ðx=IÞs þ b; ð1Þ
where B is the specific binding of the agonist normalized to control
binding (in the absence of GTP-c-S), x is the concentration of GTP-
c-S, a is the range (ymax  ymin) of the fitted curve on the ordinate
(y-axis), I is the IC50 concentration, b is the background of the fitted
curve (ymin), and s is the slope factor. The difference between inhibition
in agonist binding obtained with the highest and the lowest concentra-
tions of GTP-c-S at a specified concentration of MgCl2 is expressed as
the extent of inhibition in agonist binding and shown in Table 1.Results and discussion
We monitored the ability of Mg2+ to modulate the
specific agonist binding to 5-HT1A receptors from bo-
vine hippocampus. Fig. 1 shows that the specific [3H]8-
OH-DPAT binding activity obtained in the absence of
MgCl2 is 17.5 fmol/mg protein while that obtained in
the presence of 10 mM MgCl2 is 53.1 fmol/mg protein.
Thus, there is 3-fold increase in the specific binding
activity when the concentration of MgCl2 is increased
up to 10 mM. This indicates that the specific binding
of the agonist [3H]8-OH-DPAT to 5-HT1A receptors is
dependent on the concentration of Mg2+ in the system.
G-protein coupled receptors (GPCRs) transduce sig-
nals from the extracellular milieu to the inside of the cell
via their interaction with heterotrimeric G-proteins lo-
cated on the cytoplasmic face of the cell. The G-protein
Fig. 1. Effect of increasing concentrations of MgCl2 on the specific
binding of the agonist [3H]8-OH-DPAT to 5-HT1A receptors from
bovine hippocampal membranes. The data points represent means ±
SE of duplicate points from three independent experiments. See
Materials and methods for other details.
Fig. 2. Effect of increasing concentrations of GTP-c-S on the specific
binding of the agonist [3H]8-OH-DPAT to 5-HT1A receptors from
bovine hippocampal membranes in the presence of 0 mM (h), 0.5 mM
(d), 2 mM (s), and 10 mM (j) MgCl2. Values are expressed as a
percentage of the specific binding obtained in the absence of GTP-c-S.
The curves are non-linear regression fits to the experimental data using
the four parameter logistic function [27]. The data points represent
means ± SE of duplicate points from three independent experiments.
See Materials and methods for other details.
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subunits. Ligand-bound receptors activate G-proteins
by facilitating GDP–GTP exchange on the a subunit
where the Ga subunit bound to GTP dissociates from
the bc pair, and both a and bc regulate their respective
downstream signaling components [22,28]. Hydrolysis
of GTP by Ga inactivates this process as the Ga reunites
with bc subunits to form the inactive heterotrimer. Due
to receptor–G-protein interaction, guanine nucleotides
are known to modulate ligand binding of G-protein cou-
pled receptors. This has been shown to be true in case of
the 5-HT1A receptor [15,29]. Thus, it has been previously
shown that the specific agonist 8-OH-DPAT and the
antagonist p-MPPF differentially discriminate G-protein
coupling of 5-HT1A receptors from bovine hippocam-
pus. In other words, while the agonist binds to only
those receptors that are coupled to G-proteins, the
antagonist binds to all receptors irrespective of their
state of G-protein coupling. Non-hydrolyzable ana-
logues such as GTP-c-S block the G-protein cycle and
thereby inhibit agonist binding to receptors (such as
the 5-HT1A receptor) [21]. Interestingly, Mg
2+ has been
shown to be a crucial component in various steps of the
G-protein cycle such as the binding of GTP to the Ga
subunit and its hydrolysis [23,27].
In order to assess the status of receptor–G-protein
interaction in case of the 5-HT1A receptor at varying
concentrations of Mg2+, we monitored the specific ago-
nist binding of the receptor in the presence of GTP-c-S.
Fig. 2 shows the inhibition of agonist binding to 5-HT1A
receptors by GTP-c-S at different concentrations of
MgCl2. As seen from the figure, in the absence of
MgCl2, agonist binding is relatively insensitive to
GTP-c-S. As the concentration of Mg2+ is increased
up to 10 mM, the inhibition in agonist binding broughtabout by GTP-c-S appears to improve significantly.
This is apparent from the extent of inhibition in agonist
binding caused by GTP-c-S at various concentrations of
Mg2+ (see Table 1). While the extent of inhibition is
modest in the absence of Mg2+ (26.6%), it increases con-
siderably (91.3%) in the presence of 10 mMMg2+. There
is therefore 3.5-fold increase in the inhibition in ago-
nist binding in the presence of GTP-c-S when the con-
centration of Mg2+ is increased from 0 to 10 mM.
Table 1 also shows that the half maximal inhibition con-
centrations (IC50) for inhibition of specific [
3H]8-OH-
DPAT binding by GTP-c-S decrease with increasing
concentrations of Mg2+. The IC50 value shows 7-fold
reduction when the concentration of Mg2+ is increased
from 0.5 to 10 mM. This indicates that much less con-
centration of GTP-c-S is required in the presence of
Mg2+ to cause the same extent of inhibition in specific
agonist binding. In other words, the presence of Mg2+
effectively makes the system more sensitive to the effect
of GTP-c-S which indicates increased coupling of the
receptor to G-proteins.
The presence of divalent metal ions such as Mg2+ is
known to inhibit antagonist p-MPPF binding to the 5-
HT1A receptor in a concentration-dependent manner
[14]. This somewhat complicates monitoring the guanine
nucleotide sensitivity of antagonist binding to 5-HT1A
receptors in the presence of Mg2+. Specific [3H]p-MPPF
binding has been reported to be inhibited to a relatively
low extent when the concentration of MgCl2 used is
2 mM [14]. Interestingly, our results (see Fig. 2) indicate
this concentration (2 mM) of MgCl2 to be sufficient to
Fig. 3. Effect of increasing concentrations of GTP-c-S on the specific
binding of the antagonist [3H]p-MPPF (d) to 5-HT1A receptors from
bovine hippocampal membranes in the presence of 2 mM MgCl2. The
sensitivity of specific agonist [3H]8-OH-DPAT binding (s) in the
presence of 2 mMMgCl2 with increasing concentrations of GTP-c-S is
shown for comparison. Values are expressed as a percentage of the
specific binding obtained in the absence of GTP-c-S. The curve
associated with agonist binding is a non-linear regression fit to the
experimental data using the 4 parameter logistic function [27]. The
data points represent means ± SE of duplicate points from three
independent experiments. See Materials and methods for other details.
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ing. We therefore monitored the guanine nucleotide sen-
sitivity of specific antagonist binding in the presence of
2 mM Mg2+ using varying concentrations of GTP-c-S.
Fig. 3 shows that the specific antagonist binding remains
by and large invariant over a wide range of GTP-c-S
concentrations used in the presence of 2 mM Mg2+. It
has earlier been reported that agonist binding is sensitive
whereas antagonist binding is insensitive to guanine
nucleotides in case of several GPCRs [29]. Considering
the significance of Mg2+ in guanine nucleotide modula-
tion of ligand binding [23], we recommend that it is
important to include Mg2+ while determining guanine
nucleotide sensitivity of ligand (agonist or antagonist)
binding.
In addition to the role of Mg2+ in the G-protein cycle,
its presence is known to modulate both agonist and
antagonist binding of the 5-HT1A receptor [9,14,24]. In
fact, metal ion modulation of ligand binding has proved
to be a characteristic feature of other important G-pro-
tein coupled receptors such as the l-opioid receptor [30].
Our results highlight two novel aspects on the role of
Mg2+ in guanine nucleotide sensitivity of agonist bind-
ing to serotonin1A receptors: (i) specific agonist binding
is relatively insensitive to GTP-c-S in the absence of
Mg2+; and (ii) the ability of GTP-c-S to inhibit specific
agonist binding is dependent on the concentration of
Mg2+, as evident from the IC50 values of GTP-c-S and
the extent of inhibition in agonist binding caused byGTP-c-S at various concentrations of Mg2+ (Table 1).
These results therefore provide new insight into the con-
centration dependence of Mg2+ in relation to guanine
nucleotide sensitivity. We show here that 2 mM Mg2+
is sufficient to determine the sensitivity of agonist bind-
ing to GTP-c-S. Based on these results, we propose an
optimum concentration of Mg2+ which could be used
in assays toward determining guanine nucleotide sensi-
tivity of ligand binding to GPCRs such as the 5-HT1A
receptor. These results are relevant in ongoing analyses
on the role of Mg2+ in the overall regulation of ligand
binding and receptor activity in the 5-HT1A receptor in
particular, and GPCRs in general, especially in the con-
text of guanine nucleotide sensitivity.Acknowledgments
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